SCHEMBL24914768

SCHEMBL24914768

COc1ccc(Cn2c(=O)c3c(c4cccnc42)CCN(Cc2ccccc2)C3)cc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CLPP Q16740 7/20 0.61
▸ MAPT P10636 2/20 0.54
▸ THRB P10828 1/20 0.54
▸ DRD2 P14416 3/20 0.52
▸ DRD4 P21917 3/20 0.52
▸ DRD3 P35462 1/20 0.52
▸ PTGDR2 Q9Y5Y4 1/20 0.49
▸ PRMT5 O14744 1/20 0.48
▸ WDR77 Q9BQA1 1/20 0.48
▸ DDB1 Q16531 1/20 0.47
▸ CRBN Q96SW2 1/20 0.47
▸ HDAC1 Q13547 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ GABRA1 P14867 1/20 0.47
▸ GABRA2 P47869 1/20 0.47
▸ ENPP2 Q13822 1/20 0.46
▸ SIGMAR1 Q99720 1/20 0.46
▸ ACHE P22303 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24914686 1.00 CLPP (0.61) CLPPMAPTTHRBDRD2DRD4
SCHEMBL30130099 0.92 MAPT (0.59) CLPPMAPTTHRBDRD2DRD4
SCHEMBL24914717 0.92 MAPT (0.59) CLPPMAPTTHRBDRD2DRD4
SCHEMBL24914448 0.92 MAPT (0.59) CLPPMAPTTHRBDRD2DRD4
SCHEMBL30130063 0.91 DRD2 (0.57) CLPPMAPTTHRBDRD2DRD4
SCHEMBL24914661 0.91 DRD2 (0.57) CLPPMAPTTHRBDRD2DRD4
SCHEMBL24914395 0.91 CLPP (0.55) CLPPDRD2DRD4DRD3DDB1
SCHEMBL24914835 0.90 MAPT (0.67) CLPPMAPTTHRBDRD2DRD4
SCHEMBL30130104 0.90 MAPT (0.67) CLPPMAPTTHRBDRD2DRD4
SCHEMBL24914704 0.89 CLPP (0.50) CLPPDRD2DRD4DRD3PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327408-A1 COMPOUNDS CONTAINING TETRAHYDRONAPHTHYRIDINONE OR TETRAHYDROPYRIDOPYRIMIDINONE SKELETON, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF CHINA PHARMACEUTICAL UNIVERSITY (CN) 2024-10-03 — — US claimed
CN-115611896-A Compound containing tetralone or tetrahydropyridopyrimidone skeleton and preparation method and pharmaceutical application thereof 中国药科大学 2023-01-17 — — CN claimed
US-20240327408-A1 COMPOUNDS CONTAINING TETRAHYDRONAPHTHYRIDINONE OR TETRAHYDROPYRIDOPYRIMIDINONE SKELETON, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF CHINA PHARMACEUTICAL UNIVERSITY (CN) 2024-10-03 — — US disclosed
WO-2023284807-A1 COMPOUND CONTAINING TETRAHYDRONAPHTHYRIDONE OR TETRAHYDROPYRIDOPYRIMIDINONE SKELETON, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF 中国药科大学 2023-01-19 — — WO disclosed
CN-115611896-A Compound containing tetralone or tetrahydropyridopyrimidone skeleton and preparation method and pharmaceutical application thereof 中国药科大学 2023-01-17 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327408-A1 COMPOUNDS CONTAINING TETRAHYDRONAPHTHYRIDINONE OR TETRAHYDROPYRIDOPYRIMIDINONE SKELETON, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF PRCP, TMPRSS15, WEE1 CLPP 7/4885MAPT 2375/4885THRB 1920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback